Navigation Links
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions
Date:5/25/2011

mer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results.  Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10-Q and Form 8-K.  Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to Amgen's business.  Unless otherwise noted, Amgen is providing this information as of May 25, 2011 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects.  Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen expects similar variability in the future. Amgen develops product candidates internally and through licensing collaborations, partnerships and joint ventures.   Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as e
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015  Depomed, Inc. (Nasdaq: DEPO ... for the quarter ended June 30, 2015. ... pain and neurology marketplace, with significant net product revenue ... value to our shareholders in both the immediate and ... Depomed. "Growth in the second quarter was led by ...
(Date:7/29/2015)... , July 29, 2015 The U.S. Food ... device called the ReShape Integrated Dual Balloon System, that ... surgery for people with obesity and one or more ... and Bariatric Surgery (ASMBS), the nation,s largest organization for ... that after careful review the FDA has approved this ...
(Date:7/29/2015)... 29 luglio 2015 Uno studio clinico ... l,ingestione quotidiana del probiotico L. reuteri di ... modifica la produzione intestinale di fattori proteici che ... somministrazione quotidiana di ceppo di L. reuteri ... utilizzando il sistema di somministrazione brevettato BIO- tract ...
Breaking Medicine Technology:Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 2Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 3Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 4Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 5Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 6Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 7Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 8Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 9Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 10Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 11Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 12Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 13Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 14Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 15American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2
... Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order ... ended June 30, 2011. For the ... increased $753,059 to $2,519,721, up 43% compared to the ... in the Company,s prescription business. Prescriptions filled increased from ...
... in global nutrition.  Abbott expects to increase its nutrition revenues ... end of 2014. China also continues to be an important part ... the year, more than 26 percent of Abbott,s global sales ... Nutrition,s global sales were in emerging markets. ...
Cached Medicine Technology:HealthWarehouse.com Reports 43% Revenue Growth Year-Over-Year 2Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market 2
(Date:7/29/2015)... ... July 29, 2015 , ... Sports fans young and ... visit by former players of the Detroit Lions, joined by A Forever Recovery, a ... Pro Bowl Wide Receiver Herman Moore, Pro Bowl Offensive Lineman Lomas Brown, and Tight ...
(Date:7/29/2015)... ... July 29, 2015 , ... VideoLink , ... Medical Center, located in New York, NY, selected the ReadyCam on-site video studio ... and scientists to immediately access worldwide TV and cable news networks and participate ...
(Date:7/29/2015)... ... July 29, 2015 , ... Gender minority people who are ... law has provided legal protections against discrimination on the basis of gender identity ... against discrimination based on gender identity in places open to the public, such ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Angelo’s FabriClean, ... its new service: water damage restoration of carpets and rugs. The company will now ... as for commercial clients. , An overflowing overhead tank, rain leaking through an ...
(Date:7/29/2015)... ... , ... The healthcare analytics market is categorized on the ... as the rising pressure to curb healthcare costs, big data in healthcare, technological ... are driving market growth. Check 149 data tables & 57 figures spread through ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5
... Nurses Strike in This Decade ... Calif. Hospitals, OAKLAND, Calif., Sept. 28 Registered nurses at ... announce plans,today for a major strike in October that could involve ... and the Fremont-Rideout,Health Group in Yuba City and Marysville. Strike ...
... tuberculosis, life-threatening drug-resistant respiratory and skin infections, and ... physicians are applauding Rep. Jim Matheson (D-UT) and ... the Strategies To Address Antimicrobial Resistance (STAAR) Act. ... has the potential to save thousands of lives, ...
... TIKVA, Israel, September 28 Healthcare,Technologies Ltd. (NASDAQ: ... reschedule,the extraordinary general meeting of its shareholders for ... Biofuels, Inc, Mac Bioventures,Inc. and Gamida for Life ... 2007, in order to allow shareholders additional time ...
... WASHINGTON, Sept. 28 The higher infant,mortality ... rights issue" and,requires a revised set of approaches ... Joint Center for Political and Economic,Studies., In ... Infant Mortality,Commission, which was established by the Joint ...
... A market-based program is improving air quality, agency claims ... nitrogen oxides (NOx) from power plants, cars and other ... -- making for less ozone and therefore less smog ... to the NOx Budget Trading Program annual report from ...
... PHILADELPHIA, Sept. 28 Independence Blue Cross,announces it ... System,and St. Mary Medical Center, both part of ... 2007. The Mercy Health System includes Mercy ... St. Agnes Continuing,Care Center, and Nazareth Hospital, as ...
Cached Medicine News:Health News:RNs to Announce October Strike of 5,500 Nurses 2Health News:Infectious diseases experts applaud bill against 'bad bugs' 2Health News:Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction 2Health News:Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction 3Health News:Joint Center Says New Approach Required to Reduce Black Infant Mortality 2Health News:Joint Center Says New Approach Required to Reduce Black Infant Mortality 3Health News:Less Smog Now in Eastern U.S.: EPA 2Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 2Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 3
7 1/2" Handswitch Monopolar Forceps, Ins., Curved, Serrated...
Dissecting Forceps, straight, with RF-cable, 7" (18 cm). For use with all electrosurgical generators with standard three-prong sockets....
Extended angled sharp electrode - 1/box....
... of the art in inverted microscopy from ... wide range of ICS objectives, with innovative ... with an unusual scope of sophisticated documentation ... ergonomically designed. And Axiovert 200 M, fully ...
Medicine Products: